Roivant Sciences LtdROIV
▲ ポジティブ資本関連度
Roivant received $772 million from Moderna settlement and repurchased shares.
資産への影響 2
Biotech & Genomic Medicine
Roivant Sciences Ltd
Moderna IncMRNA
▼ ネガティブ資本関連度
Moderna paid a $950 million settlement to Roivant, reducing its cash.
テーマインパクト
カバレッジ外企業 1
Genevant Sciences非上場▲ ポジティブ
資本関連度
Genevant received approximately $770 million from the Moderna settlement.